Parabilis Medicines, Inc. Restricted Cash and Cash Equivalents
Parabilis Medicines, Inc. (PBLS) had Restricted Cash and Cash Equivalents of $1.09 billion as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-13
- 2026-06-30: Restricted Cash and Cash Equivalents $1.09B.
- 2025-06-30: Restricted Cash and Cash Equivalents $83.25M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2026-06-30 | $1.09B 10-Q · filed 2026-08-13 |
| 2025-06-30 | $83.25M 10-Q · filed 2026-08-13 |